NEUP סך נכסי הפעילות העסקית Neuphoria

Neuphoria Therapeutics Inc. (NEUP) is implementing AI and robotics to automate the development of neuropreparations, minimizing the human factor in laboratories. This chart available on the page demonstrates the dynamics of total assets, which currently stand at 0.00. Neuphoria Therapeutics Inc. (NEUP) creates antidepressants through the precise modulation of brain ion channels. The business is currently focusing on molecule validation, which requires continuous funding to expand the pipeline.

Neuphoria Therapeutics Inc. (NEUP) automates the creation of neuropreparations through AI and robotic bioscreening, which requires significant capital expenditures in technological infrastructure. The total value of resources, reverse-calculated via ROA, demonstrates a balance between equity and liabilities, allowing the investor to assess the stability of the base against external shocks across the trajectory of all company resources.